These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28220465)

  • 21. Combined serum free light chain levels are associated with carotid atherosclerosis in type 2 diabetes mellitus.
    Aberer F; Tripolt NJ; Scharnagl H; Zedler J; Eder M; Oulhaj A; Stojakovic T; Sourij H
    Diab Vasc Dis Res; 2018 Mar; 15(2):162-164. PubMed ID: 29189047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges.
    Gore MO; McGuire DK; Lingvay I; Rosenstock J
    Curr Cardiol Rep; 2015 Jul; 17(7):607. PubMed ID: 26031671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk in type 2 diabetes.
    Standl E
    Diabetes Obes Metab; 1999 Sep; 1 Suppl 2():S24-36. PubMed ID: 11221799
    [No Abstract]   [Full Text] [Related]  

  • 24. [Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].
    Nadal JF; Gutiérrez PC
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():7-13. PubMed ID: 24444518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is type 2 diabetes really a coronary heart disease risk equivalent?
    Saely CH; Drexel H
    Vascul Pharmacol; 2013; 59(1-2):11-8. PubMed ID: 23702159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening and risk stratification of patients with the metabolic syndrome and diabetes.
    Wong ND
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):181-90. PubMed ID: 16509814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triglycerides in diabetes: time for action?
    Stewart MW; Laker MF
    Diabet Med; 1994 Oct; 11(8):725-7. PubMed ID: 7851064
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.
    McVeigh GE; Gibson W; Hamilton PK
    Diabetes Obes Metab; 2013 Mar; 15(3):198-203. PubMed ID: 22998614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular mechanisms of diabetic cardiovascular disease.
    Hupfeld CJ; Wong GA
    Prev Cardiol; 2002; 5(4):183-7. PubMed ID: 12417827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.
    Huerta MG; Nadler JL
    Curr Diab Rep; 2002 Oct; 2(5):396-402. PubMed ID: 12643164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis.
    Lehtinen AB; Burdon KP; Lewis JP; Langefeld CD; Ziegler JT; Rich SS; Register TC; Carr JJ; Freedman BI; Bowden DW
    J Clin Endocrinol Metab; 2007 Jan; 92(1):345-52. PubMed ID: 17062776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin for primary prevention of cardiovascular events in people with diabetes.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
    [No Abstract]   [Full Text] [Related]  

  • 35. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria.
    von Scholten BJ; Reinhard H; Hansen TW; Schalkwijk CG; Stehouwer C; Parving HH; Jacobsen PK; Rossing P
    J Diabetes Complications; 2016 Mar; 30(2):248-55. PubMed ID: 26651261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic vascular disease.
    Feingold KR; Siperstein MD
    Adv Intern Med; 1986; 31():309-40. PubMed ID: 3511622
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diabetic complications in newly-diagnosed non-insulin-dependent diabetes].
    Uusitupa M; Siitonen O; Lehtinen J; Teräsvirta M; Pyörälä K
    Duodecim; 1986; 102(15):1024-34. PubMed ID: 3757840
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk.
    Rodriguez-Poncelas A; Coll-de-Tuero G; Saez M; Garrido-Martín JM; Millaruelo-Trillo JM; Barrot de-la-Puente J; Franch-Nadal J;
    BMC Cardiovasc Disord; 2015 Oct; 15():121. PubMed ID: 26464076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Family history of diabetes predisposes to cardiovascular disease among patients with type 2 diabetes: What is the nature of the association?
    Bonnet F; Balkau B; Natali A
    Diabetes Metab; 2016 Jun; 42(3):139-41. PubMed ID: 27255507
    [No Abstract]   [Full Text] [Related]  

  • 40. High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with Type 1 and Type 2 diabetes.
    Hansen CS; Fleischer J; Vistisen D; Ridderstråle M; Jensen JS; Jørgensen ME
    Diabet Med; 2017 Mar; 34(3):364-371. PubMed ID: 27696502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.